Navigation Links
Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity
Date:9/10/2013

the pooled MezzoTinA-asthma® results.

In the individual trials and the pooled analysis being presented at ERS, the mean change in peak FEV1 at 24 weeks from baseline versus placebo was significantly improved for all three active treatments:MezzoTinA-
asthma® 1

MezzoTinA-
asthma® 2

Pooled AnalysisAdjusted mean
FEV1 AUC0-3
difference from
placebo

Adjusted mean
FEV1 AUC0-3
difference from
placebo

Adjusted mean
FEV1 AUC0-3
difference from
placeboTiotropium 2.5 mcg

236 mL
(P < 0.0001)

211 mL
(P < 0.0001)

223 mL

(P < 0.0001)Tiotropium  5 mcg

198 mL
(P < 0.0001)

169 mL
(P < 0.0001)

185 mL
(P < 0.0001)Salmeterol 50 mcg

213 mL
(P < 0.0001)

176 mL
(P < 0.0001)

196 mL
(P < 0.0001)Additionally, the mean change in trough FEV1 at 24 weeks from baseline versus placebo in the individual trials, as well as in the pooled data being presented at ERS, was significantly improved for all three active treatments:MezzoTinA-
asthma® 1

MezzoTinA-
asthma® 2

Pooled AnalysisAdjusted mean
trough FEV1
difference from
placebo

Adjusted mean
trough FEV1
difference from
placebo

Adjusted mean
trough FEV1
difference from
placeboTiotropium 2.5 mcg

185 mL
(P < 0.0001)

176 mL
(P < 0.0001)

180 mL

(P < 0.0001)Tiotropium  5 mcg

152 mL
(P < 0.0001)

133 mL
(P < 0.0001)

146 mL
(P < 0.0001)Salmete
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takedas New Investigational Drug Vedolizumab is Granted Priority Review Status by U.S. Food and Drug Administration for Ulcerative Colitis
2. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
3. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
4. New Data for Abbotts Investigational High Sensitive Troponin Test Shows It May Help Doctors Predict Heart Attack Risk
5. Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
6. Signum Dermalogix Investigational New Drug (IND) Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea
7. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
8. Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
9. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
10. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
11. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) today reported ... June 30, 2015 and updated its financial guidance for ... this morning, August 4, 2015, at 10:30 AM ET. ... by dialing (855) 582-8078. The conference ID is 90889796. ... revenues of $38.3 million, an increase of 118% as compared ...
(Date:8/3/2015)... Ill. , Aug. 3, 2015  Landauer, Inc. ... and environmental radiation measurement and monitoring, outsourced medical physics ... it will release financial results for the fiscal third ... 10, 2015. The Company will also ... 11, 2015 at 9:00 a.m. Central Time (10:00 a.m. ...
(Date:8/3/2015)... (Nasdaq: DRRX ) announced today financial results for the ... net loss was $5.5 million for the three months ended ... million and net loss of $5.5 million for the three ... cash and investments of $37.8 million, compared to cash and ... 30, 2015, we had $19.8 million in long term debt. ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10
... ANNAPOLIS, Md. and FAYETTEVILLE, Ark., April 4, 2012 ... provider SOAPware, Inc. have forged a strategic ... care practices transition from paper-based records to ... (EHR/EMR) systems. Together, the companies will work ...
... Texas Instruments Incorporated (TI) (NASDAQ: TXN ) ... family with five new fully integrated AFEs for portable ... (EEG) AFEs are the first to offer 16- and ... cut power consumption by more than 94 percent compared ...
Cached Medicine Technology:Syndicus, Inc. Scientific Services, SOAPware Announce Strategic Alliance 2TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 2TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 3TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 4TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 5
(Date:8/4/2015)... ... 04, 2015 , ... Oriental Trading Company, Inc., the nation’s ... school supplies, has developed engaging and affordable teacher supplies based on the beloved ... rewards, classroom decorations, crafts and educational resources featuring Carle’s vibrant illustrations and inspirational ...
(Date:8/4/2015)... ... August 04, 2015 , ... More than 700 years of marital ... vows on Friday, July 24th. Chaplains Shawn Kafader and Richard Oas lead the ... Following the ceremony was a reception, with music by the Moonlight Serenade Orchestra and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Loyola University ... that its RN to BSN and Master of Science in Nursing in ... June 2020 from the Commission on Collegiate Nursing Education (CCNE), the ...
(Date:8/4/2015)... ... 04, 2015 , ... Lightning Labels is pleased to announce ... will usher in a new standard of sticker and label-making for the company. ... its twin objectives of quality and quantity without compromising the signature lightning-fast speed ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... their partnership to make the Isabel Symptom Checker available to all users of ... a mechanism to check their symptoms in an easy, intuitive method, provides access ...
Breaking Medicine News(10 mins):Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 2Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 3Health News:Couples Renew Vows at Friendship Village of Schaumburg 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 4Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3
... FRANKLIN LAKES, N.J., Jan. 16 BD (Becton,Dickinson and ... company,announced today that it will host a live webcast ... 2008, at 1 p.m. (ET)., The webcast can ... and will be available for replay through Tuesday,February ...
... Agreement Provides for Provider Services, Inc. to fund $600,000 for Product, ... Millennium pursuant to the terms of the $20,000,000 5-year Purchase ... ... N.J., Jan. 16 Millennium Biotechnologies,Inc., wholly owned subsidiary of Millennium ...
... STERIS Corporation,(NYSE: STE ) today announced that ... release before the market opens on January 30, ... Eastern time. The conference,call can be heard live ... via phone,by dialing 1-888-392-9976 in the United States ...
... 16 OMI Medical Imaging, Inc. (OMI),announced today that ... with the U.S. Bankruptcy Court for the Southern District ... Reduction Act reimbursement cuts took effect on,January 1, 2007, ... to its secured lenders., OMI operates 21 free ...
... will respond best to interferon beta treatments , WEDNESDAY, ... why some multiple sclerosis (MS) patients respond to treatment ... with 206 southern European patients with relapsing-remitting MS, the ... the DNA of patients whose symptoms were reduced by ...
... The School of Dentistry at LSU Health Sciences Center ... dental institution recipient of the William J. Gies Award ... the ADEAGies Foundation at a black-tie celebration on March ... Education Association (ADEA) Annual Session at the Hilton Anatole ...
Cached Medicine News:Health News:Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc. 2Health News:STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 2Health News:STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 3Health News:OMI Medical Imaging, Inc. and Affiliated Companies File Chapter 11 Reorganization 2Health News:DNA Analysis Could Help Customize Treatments for MS 2Health News:LSUHSC dental school to be awarded top national honor 2
Fine & Medium Tapers....
Contour Design Eyelid Implants....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
Medicine Products: